Stoke Therapeutics Inc diskutieren
Stoke Therapeutics Inc
WKN: A2PLTL / Symbol: STOK / Name: Stoke Therapeutics / Aktie / Biotechnologie & medizinische Forschung / ? /
28,00 €
6,87 %
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics, Inc. (NASDAQ: STOK) was given a new $28.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at Needham & Company LLC from $22.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics (NASDAQ:STOK) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $39.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at Wedbush from $22.00 to $32.00. They now have an "outperform" rating on the stock.
Ratings data for STOK provided by MarketBeat
Neueste Beiträge
Roth_Capital in Lakeland Industries Inc. diskutieren